|
David Brudnoy Fund at MGH receives
$400,000 bequest from Brudnoy estate
Unrestricted donation to support
MGH AIDS endeavors
BOSTON - December 8, 2005 - The David Brudnoy Fund for AIDS
Research at the Massachusetts General Hospital (MGH) has received
$400,000 from the estate of David Brudnoy. The well-known and respected
Boston radio commentator and talk show host named the fund as a
beneficiary of his will. The unrestricted bequest will be presented
to the hospital Dec. 9, the first anniversary of Brudnoy's death
from cancer.
"David was very committed to helping others with HIV and AIDS,"
said Ward Cromer, a long-time friend of Brudnoy's and executor of
his estate. "He started the Brudnoy Fund in order to support
MGH in its efforts to provide flexible and innovative research."
The David Brudnoy Fund for AIDS Research was created by Brudnoy
a decade ago following a very public hospitalization during his
battle with AIDS. Established to raise private and corporate support
for basic and clinical AIDS research at the MGH and the hospital's
HIV/AIDS initiatives in Durban, South Africa, this funding is critical
to giving MGH researchers the flexibility required to respond to
new discoveries and quickly apply them to patient care.
"At the MGH and other leading researcher institutions, efforts
to explore exciting new avenues of research are confounded by reductions
in traditional sources of funding," says Bruce Walker, MD,
director of the Partners
AIDS Research Center at the MGH. "Some of our young investigators
with innovative approaches find it particularly difficult to get
the grants needed to pursue what may turn out to be revolutionary
approaches to defeating HIV. The type of funding that the Brudnoy
Fund provides allows our investigators to explore projects that
otherwise might go without adequate funding."
Several of the projects supported by the fund include the David
Brudnoy Innovative Research Fund, which provides rapid support for
innovative new research approaches to HIV/AIDS prevention and treatment
and vaccines; the creation of the David Brudnoy HIV Scholar Award,
presented once a year to provide funding support for promising young
AIDS researchers at MGH; and a new program that places MGH residents
in Africa at the heart of the epidemic where human and infrastructure
resources are stretched beyond the limit, and where these residents
serve as mentors, training local physicians, medical students and
nurses in optimal medical care, thus playing a pivotal role in building
the next generation of AIDS researchers.
"This contribution is a reminder of the continuous support
David provided to others," says Cromer. "And it is a challenge
to all of us to pick up where he left off." For more information
about the David Brudnoy Fund for AIDS Research at the MGH, contact
the MGH Development Office at 617-726-2200.
Massachusetts General Hospital, established in 1811, is the original
and largest teaching hospital of Harvard Medical School. The MGH
conducts the largest hospital-based research program in the United
States, with an annual research budget of nearly $500 million and
major research centers in AIDS, cardiovascular research, cancer,
cutaneous biology, medical imaging, neurodegenerative disorders,
transplantation biology and photomedicine. In 1994, MGH and Brigham
and Women's Hospital joined to form Partners HealthCare System,
an integrated health care delivery system comprising the two academic
medical centers, specialty and community hospitals, a network of
physician groups, and nonacute and home health services.
Media Contact: Michelle
Marcella, MGH Public Affairs
Physician Referral Service: 1-800-388-4644
Information about Clinical Trials
|
|
 |
